Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
What Happens When A Biotech Stock Blows Up: How Our Hedged Portfolio Method Limited The Damage With Cassava Sciences
01:42pm, Saturday, 11'th Sep 2021
Screen capture via Cassava Sciences' video for their Simulfilam Alzheimer's disease treatment. When A Biotech Stock Goes The Wrong Way
SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.
07:46pm, Friday, 10'th Sep 2021
New York, New York--(Newsfile Corp. - September 10, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Cassava Sci
New York, New York--(Newsfile Corp. - September 10, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cassava Sciences, Inc. (NASDAQ: SAV
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the
Do Options Traders Know Something About Cassava Sciences (SAVA) Stock We Don't?
10:51am, Friday, 10'th Sep 2021
Investors need to pay close attention to Cassava Sciences (SAVA) stock based on the movements in the options market lately.
Los Angeles, California--(Newsfile Corp. - September 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cassava Science
New York, New York--(Newsfile Corp. - September 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
Cassava Shareholder Alert
05:54pm, Thursday, 09'th Sep 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cassava To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Co
Los Angeles, California--(Newsfile Corp. - September 9, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cassava Sciences
Cassava Sciences to Present at H.C. Wainwright's 23rd Annual Global Investment Conference
08:15am, Thursday, 09'th Sep 2021
AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer's disease, announced today that management will pre
Cassava Sciences Stock Still Poses Risks After Absorbing Data Controversy
06:00am, Thursday, 09'th Sep 2021
Simufilam's eventual approval is still uncertain. Its fading popularity among the Reddit set is a concern as well.
7 Busted Biotech Stocks Due for a Rebound
12:25pm, Wednesday, 08'th Sep 2021
Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally. The post 7 Busted Biotech Stocks Due for a Rebound appeared first on
Kessler Topaz Meltzer & Check, LLP Reminds Cassava Sciences, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
12:12pm, Wednesday, 08'th Sep 2021
Radnor, Pennsylvania--(Newsfile Corp. - September 8, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Ca
Philadelphia, Pennsylvania--(Newsfile Corp. - September 8, 2021) - Berger Montague is investigating securities fraud allegations against Cassava Sciences Inc. ("Cassava" or the "Company"). The Firm is
San Diego, California--(Newsfile Corp. - September 7, 2021) - Robbins Geller Rudman & Dowd LLP filed a class action lawsuit charging Cassava Sciences, Inc. (NASDAQ: SAVA) and certain of its executives
